Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on US Healthcare Journal.
April 2025
Mo | Tu | We | Th | Fr | Sa | Su |
---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | 6 | |
7 | 8 | 9 | 10 | 11 | 12 | 13 |
14 | 15 | 16 | 17 | 18 | 19 | 20 |
21 | 22 | 23 | 24 | 25 | 26 | 27 |
28 | 29 | 30 |
May 2025
Mo | Tu | We | Th | Fr | Sa | Su |
---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | |||
5 | 6 | 7 | 8 | 9 | 10 | 11 |
12 | 13 | 14 | 15 | 16 | 17 | 18 |
19 | 20 | 21 | 22 | 23 | 24 | 25 |
26 | 27 | 28 | 29 | 30 | 31 |
June 2025
Mo | Tu | We | Th | Fr | Sa | Su |
---|---|---|---|---|---|---|
1 | ||||||
2 | 3 | 4 | 5 | 6 | 7 | 8 |
9 | 10 | 11 | 12 | 13 | 14 | 15 |
16 | 17 | 18 | 19 | 20 | 21 | 22 |
23 | 24 | 25 | 26 | 27 | 28 | 29 |
30 |
Press releases published on May 24, 2025

DMARC MSP Case Study: 1-MSP Boosts Client Security & Deliverability with PowerDMARC
ORLANDO, FL, UNITED STATES, May 24, 2025 /EINPresswire.com/ -- As email threats continue to rise, managed service providers are under growing pressure to deliver scalable, effective domain protection to clients. 1-MSP, a leading US-based managed IT …

Rx-Credentialing Achieves Milestone: Over 100 NPs and MDs Engaged with High Retention Rates
Premium Medical Billing Service is proud to announce that the company now serves over 100 nurse practitioners (NPs) and medical doctors (MDs) across New York. NEW YORK , NY, UNITED STATES, May 24, 2025 /EINPresswire.com/ -- RxCredentialing, a premier …

Blue Sky Scrubs Unveils the Trinity Layering Scrubs Top: Ultra-Smooth, Stretchy, and Dreamy to the Touch
Blue Sky Scrubs Unveils the Trinity Layering Scrubs Top: Ultra-Smooth, Stretchy, and Dreamy to the Touch- Since 2005 Boutique Scrubs Designed In Austin, Texas AUSTIN, TX, UNITED STATES, May 24, 2025 /EINPresswire.com/ -- Blue Sky Scrubs, a pioneer in …

Village Emergency Room & Urgent ER Care Clinic Enhances 24/7 Access to Emergency Services in League City
LEAGUE CITY, TX, UNITED STATES, May 24, 2025 /EINPresswire.com/ -- Village Emergency Room …

New Comprehensive Rodent Models Developed by Creative Biolabs Aim to Improve Disease Research
Creative Biolabs has recently expanded its research in non-transgenic rodent models to meet the growing diversity of non-clinical study needs. SHIRLEY, NY, UNITED STATES, May 24, 2025 /EINPresswire.com/ -- Creative Biolabs has recently expanded its …

Creative Diagnostics Advances Influenza Antiviral Drug Discovery with Comprehensive Screening and Evaluation Services
Creative Diagnostics has announced its comprehensive suite of services for Influenza Antiviral Drug Screening and Evaluation. NEW YORK, NY, UNITED STATES, May 24, 2025 /EINPresswire.com/ -- As an expert in providing solutions to assist virology and …

Creative Diagnostics Launches Highly Sensitive T7 RNA Polymerase ELISA Kits for Biopharmaceutical Impurity Detection
Creative Diagnostics has released T7 RNA Polymerase ELISA Kits for the detection and quantitative determination of T7 RNA Polymerase. NEW YORK, NY, UNITED STATES, May 24, 2025 /EINPresswire.com/ -- Creative Diagnostics, a leading manufacturer and …

SpringWorks Therapeutics erhält positive CHMP-Stellungnahme für Mirdametinib zur Behandlung erwachsener und pädiatrischer Patienten mit NF1-PN
– im Falle einer Marktzulassung wäre Mirdametinib die erste und einzige Behandlung in der Europäischen Union für Erwachsene und Kinder mit NF1-PN – – die Entscheidung der Europäischen Kommission wird für das dritte Quartal 2025 erwartet – STAMFORD, Conn., …

SpringWorks Therapeutics recibe un dictamen positivo del CHMP para el uso de mirdametinib en el tratamiento de la NF1-NP en pacientes adultos y pediátricos
– Si se aprueba, se espera que el mirdametinib sea la primera y única terapia autorizada para el tratamiento de la NF1-NP en la Unión Europea, tanto para adultos como para niños – – Decisión de la Comisión Europea prevista en el tercer trimestre de 2025 – …

SpringWorks Therapeutics reçoit un avis favorable du CMUH pour l’utilisation du mirdamétinib pour le traitement des patients adultes et pédiatriques atteints de NF1-PN
– S’il est approuvé, le mirdamétinib devrait être le premier et unique traitement dans l’Union européenne à bénéficier d’une autorisation de mise sur le marché pour les adultes et les enfants atteints de NF1-PN – – La décision de la Commission européenne …

SpringWorks Therapeutics: CHMP valuta positivamente Mirdametinib per il trattamento di pazienti adulti e pediatrici affetti da NF1-PN
– Se approvato, mirdametinib sarà la prima e unica terapia nell'Unione europea a ottenere l'autorizzazione all'immissione in commercio sia per gli adulti che per i bambini affetti da NF1-PN – – La decisione della Commissione europea è prevista nel terzo …

SpringWorks Therapeutics krijgt positief advies van de CHMP voor Mirdametinib voor de behandeling van volwassen en pediatrische patiënten met NF1-PN
- Als mirdametinib wordt goedgekeurd, zal het naar verwachting de eerste en enige therapie in de Europese Unie zijn met een handelsvergunning voor zowel volwassenen als kinderen met NF1-PN - - Besluit van de Europese Commissie wordt verwacht in het derde …

Now Accepting Applications: iHope Genetic Health Clinical Sites
Pass it on! DAMASCUS, MD, UNITED STATES, May 23, 2025 /EINPresswire.com/ -- Genetic Alliance is now accepting applications for new clinical sites to join the iHope Genetic Health (iGH) program, which provides no-cost genomic testing to families from low …